Value Bridge — ST. MARY MEDICAL CENTER INC.
Current $30M → Target $37M (+$7.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$30.4M
Current EBITDA
$37.4M
Target EBITDA
+$7.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.6M
Payer Mix Optimization
$3.8M
Cost to Collect Reduction
$1.3M
Clean Claim Improvement
$1.0M
Volume & Rate Growth
$6.4M
What This Means
The 7-lever model projects a 23% EBITDA uplift from $30M to $37M. The highest-impact lever is Volume & Rate Growth at $2.6M probability-weighted.
IC talking point: "We see $7M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $78M in equity value creation."